All
 
|
 
 


Chinese healthcare system: Genesis, reforms and response to the COVID-19 pandemic
 
PIIS032150750019749-5-1
DOI10.31857/S032150750019749-5
Publication type Article
Status Published
Authors
Maryana Gubina 
Occupation: Associate Professor
Affiliation: Saint Petersburg State University
Address: Russian Federation, Saint Petersburg
Daria Terenteva
Affiliation: Saint Petersburg State University
Address: Russian Federation, Saint Petersburg
Journal nameAsia and Africa Today
EditionIssue 9
Pages46-52
Abstract

The public health system is an important institutional mechanism for reducing society’s medical burden, improving people’s well-being, and, consequently, maintaining harmony and stability in society.

This article is devoted to analysis of the development of the health care system of the People’s Republic of China. In particular, the article discusses the main problems of the last four decades of the PRC health system (since 1978 when reforms and opening-up were launched in China); current reforms in this area; as well as the impact of the COVID-19 pandemic on the PRC health system.

The COVID-19 pandemic has revealed serious problems in the Chinese healthcare system: lack of resources (medical personnel, healthcare facilities, beds, modern medical equipment), modest investments by the state, exorbitantly high prices for healthcare services and medicines, distrust of doctors by the population, etc. At the same time, in 2020-2021, China has shown an example of a successful fight against the dangerous virus. The Chinese strategy is based on a policy of “zero tolerance” for COVID-19.

This means limiting the spread of the virus through lockdowns, providing mass testing, as well as the conversion of public spaces into COVID hospitals, and the use of high technology in health care (Big Data, mobile health, etc.) were found to be decisive measures. Due to those actions, People’s Republic of China was able to recover from virus fairly quickly and show comparatively good economic results in 2020 and 2021.

The outbreak of the new strain of coronavirus occurred in China in mid-2022 and a strict lockdown was introduced in some cities and provinces. The article analyzes the reasons of criticism of the “zero tolerance” policy by the World Health Organization under such circumstances.

Keywordshealthcare system, PRC, reforms, traditional Chinese medicine, COVID-19 pandemic
Received14.04.2022
Publication date13.09.2022
Number of characters23388
Cite  
100 rub.
When subscribing to an article or issue, the user can download PDF, evaluate the publication or contact the author. Need to register.

Number of purchasers: 0, views: 303

Readers community rating: votes 0 

1. Carvalho T., Krammer F., Iwasaki A. 2021. The first 12 months of COVID-19: a timeline of immunological insights. Nature Reviews Immunology. № 4, pp. 245-256.
2. China Statistical Yearbook 2021. http://www.stats.gov.cn/tjsj/ndsj/2021/indexeh.htm  (accessed 06.02.2022)
3. Dai C.T., Duchâtel M. 2009. New Reforms to the Health System. China perspectives. № 79, pp. 108-111.
4. Hesketh T., Zhu W.X. Health in China: traditional Chinese medicine: one country, two systems. Bmj. 1997. Vol. 315. № 7100, pp. 115-117.
5. Ho B., Tsai T. 2004. The Chairman and the Coronavirus. Harvard International Review. № 4, p. 29.
6. Johns Hopkins University. Coronavirus Recourse Center. https://coronavirus.jhu.edu/map.html  (accessed 20.03.2022)
7. Li L., Chen Q., Powers D. 2012. Chinese healthcare reform: a shift toward social development. Modern China. Vol. 38. № 6, p. 631.
8. Narain J.P., Dawa N., Bhatia R. 2020. Health System Response to COVID-19 and Future Pandemics. Journal of Health Management. Vol. 22, Issue 2.
9. Sun S. et al. 2021. COVID-19 and healthcare system in China: challenges and progression for a sustainable future. Globalization and Health. Vol. 17. № 1, pp. 1-8.
10. Tao W. et al. 2020. Towards universal health coverage: lessons from 10 years of healthcare reform in China. BMJ global health. Vol. 5. № 3, pp. 6-8.
11. World Bank World Development Indicators. https://data.worldbank.org/indicator/SP.DYN.LE00.IN?end=2019&locations=CN&  start=1960&view=chart (accessed 05.02.2022)
12. Gubina M.A. 2022. COVID-19 pandemic as a driver of global vaccine market development. The Sixth International Economic Symposium - 2022. Eds. O.L.Margania, S.A.Belozerov, et al. St. Petersburg (In Russ.).
13. Gubina M.A. 2008. Modern models of health care: the experience of developed countries. Vestnik of Saint Petersburg University. Economics. № 1 (In Russ.).
14. Pekhtereva E.A. 2021. Reforming the Chinese Healthcare System and the Development of the Medical Services Market during the COVID-19 Pandemic. Economic and Social Problems of Russia. № 2 (In Russ.).
15. Our World in Data COVID-19 dataset. https://ourworldindata.org/covid-vaccinations?country=OWID_WRL  (accessed 20.06.2022)

Система Orphus

Loading...
Up